TRxADE HEALTH (NASDAQ:MEDS) Trading Down 0.6% – What’s Next?

TRxADE HEALTH, Inc. stock price. (NASDAQ:MEDS – Get Free Report ) was down 0.6% during trading on Monday. The stock traded as high as $6.99 and last traded at $6.99. About 6,486 shares traded hands during mid-day trading, down 97% from the average daily volume of 207,831 shares. Shares previously closed at $7.03.

TRxADE HEALTH trading down 1.6%

The firm has a fifty day moving average price of $7.42 and a 200 day moving average price of $8.75.

TRxADE HEALTH (NASDAQ:MEDS – Get Your Free Report ) last released its quarterly earnings data on Friday, August 9th. The company reported ($1.04) earnings per share (EPS) for the quarter. TRxADE HEALTH had a negative net margin of 149.81% and a negative return on equity of 196.79%. The business had revenue of $0.02 million during the quarter.

Institutional investors are investing in TRxADE HEALTH

An institutional investor recently bought a new position in shares of TRxADE HEALTH. Virtu Financial LLC bought a new stake in TRxADE HEALTH, Inc. (NASDAQ:MEDS – Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 10,617 shares of the company’s stock, valued at approximately $109,000. Virtu Financial LLC owned about 0.75% of TRxADE HEALTH at the end of the most recent quarter. 5.68% of the shares are currently held by hedge funds and other institutional investors.

About TRxADE HEALTH

(Get a free report)

TRxADE HEALTH, Inc operates as a healthcare information technology (IT) company in the United States. The company focuses on digitizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement; and designs, develops, owns and operates a business-to-business web-based marketplace.

Recommended articles

Receive daily news and reviews for TRxADE HEALTH – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for TRxADE HEALTH and related companies with MarketBeat.com ‘s FREE daily email newsletter.